
51 - 200 employees
Founded 2016
π₯ Healthcare
πΌ Consulting
βοΈ Legal
Healthcare β’ Consulting β’ Legal
Immunic Therapeutics is a late-stage biotechnology company focused on developing novel, orally administered small-molecule therapies for chronic inflammatory and autoimmune diseases, with particular programs targeting multiple sclerosis and celiac disease. The company advances differentiated clinical-stage programs (e. g. , vidofludimus calcium, IMU-856, IMU-381) aiming to provide efficacious, safe, and well-tolerated oral treatment options for neurologic and gastrointestinal immune-mediated conditions, while pursuing regulatory protections and commercialization pathways.
π October 29
πΊπΈ United States β Remote
π΅ $285k - $340k / year
β° Full Time
π΄ Lead
π Vice President
π» Ghost score 4%
Where this job comes from
Posted on Immunic Therapeutics's careers page β, not through a job board
First seen by Remote Rocketship October 29
Still open on Immunic Therapeutics's site. Checked 37 minutes ago.

51 - 200 employees
Founded 2016
π₯ Healthcare
πΌ Consulting
βοΈ Legal
Healthcare β’ Consulting β’ Legal
Immunic Therapeutics is a late-stage biotechnology company focused on developing novel, orally administered small-molecule therapies for chronic inflammatory and autoimmune diseases, with particular programs targeting multiple sclerosis and celiac disease. The company advances differentiated clinical-stage programs (e. g. , vidofludimus calcium, IMU-856, IMU-381) aiming to provide efficacious, safe, and well-tolerated oral treatment options for neurologic and gastrointestinal immune-mediated conditions, while pursuing regulatory protections and commercialization pathways.
β’ Lead U.S. Market Access strategy and organization build for vidofludimus calcium's launch, covering pricing, contracting, reimbursement, and distribution β’ Develop integrated access strategies spanning Commercial, Medicare, Medicaid, VA, DoD, and other government channels β’ Own national payer strategy and negotiate with health plans, PBMs, IDNs, health systems, and specialty pharmacies β’ Build payer value propositions using clinical, economic, and real-world evidence to drive favorable formulary coverage β’ Set pricing strategy, gross-to-net assumptions, and specialty pharmacy/trade/distribution frameworks β’ Partner with Medical Affairs/HEOR on payer evidence strategy, AMCP dossiers, and value communication; support post-launch evidence generation β’ Serve on the Commercial Leadership Team and coordinate with Marketing, Sales, Medical, Regulatory, Finance, Legal, and Supply Chain on launch readiness β’ Design and build the Market Access organization structure, capabilities, and metrics across Payer Strategy, Marketing, Pricing/Contracting, Trade, Analytics, and Excellence functions β’ Recruit and lead a field Market Access team including National, Federal, and Regional Account Managers plus Field Reimbursement Managers β’ Set field deployment strategy covering territories, hiring, training, and incentives; collaborate with Sales and Medical Affairs to maximize adoption
β’ Bachelor's degree required β’ MBA, PharmD, MPH, or other advanced degree preferred β’ 15+ years of progressive leadership experience within the pharmaceutical or biotechnology industry β’ Demonstrated success leading U.S. Market Access organizations for specialty pharmaceutical products β’ Direct experience leading the U.S. Market Access strategy for one or more multiple sclerosis product launches strongly preferred β’ Significant leadership role in the commercialization of successful MS therapies strongly favored β’ Deep understanding of multiple sclerosis competitive dynamics, payer landscape, specialty pharmacy networks, treatment centers, and reimbursement environment β’ Experience negotiating with commercial payers, PBMs, Medicare Part D plans, federal healthcare systems, specialty pharmacies, and integrated health systems β’ Demonstrated success building and leading field-based Market Access organizations β’ Experience building commercial infrastructure within an emerging biotechnology company or first-launch organization strongly preferred β’ Must be authorized to work in the US
β’ Equity β’ Bonus
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
π October 29
Vice President guiding veterinarian recruitment, development, and clinical excellence at Western Veterinary Partners. Leading medical advisory and strategic initiatives across a veterinary practice network.
πΊπΈ United States β Remote
π΅ $200k - $230k / year
π° Venture Round on 2023-03
β° Full Time
π΄ Lead
π Vice President
π October 29
Vice President of Operations leading 75+ veterinary hospitals and a $250Mβ$300M P&L. Driving growth, profitability, acquisitions, and leadership development for Western Veterinary Partners.
πΊπΈ United States β Remote
π΅ $220k - $250k / year
π° Venture Round on 2023-03
β° Full Time
π΄ Lead
π Vice President
π October 29
Healthcare consulting AVP leading technology transformation, AI adoption, and change management engagements. Advising executives and driving adoption across complex health systems.
πΊπΈ United States β Remote
π΅ $125k - $145k / year
π° Private Equity Round on 2012-12
β° Full Time
π Senior
π΄ Lead
π Vice President
π October 29
Vice President advising healthcare technology and digital health organizations through strategic communications. Leading client relationships, communications programs, business development, and consulting team growth.
πΊπΈ United States β Remote
π΅ $165k - $190k / year
π° Private Equity Round on 2012-12
β° Full Time
π΄ Lead
π Vice President
π October 29
VP leading REGENXBIOβs rare disease gene therapy portfolio, P&L, and commercialization strategy. Directing the RGX-202 U.S. launch and cross-functional franchise growth.
πΊπΈ United States β Remote
π΅ $289k - $410k / year
π₯ Funding within the last year
π° $100M Post-IPO Equity on 2026-07
β° Full Time
π΄ Lead
π Vice President